After antigenic challenge, B cells enter the dark zone (DZ) of germinal centers (GCs) to proliferate and hypermutate their immunoglobulin genes. Mutants with greater affinity for the antigen are positively selected in the light zone (LZ) to either differentiate into plasma and memory cells or reenter the DZ. The molecular circuits that govern positive selection in the GC are not known. We show here that the GC reaction required biphasic regulation of expression of the cell-cycle regulator c-Myc that involved its transient induction during early GC commitment, its repression by Bcl-6 in DZ B cells and its reinduction in B cells selected for reentry into the DZ. Inhibition of c-Myc in vivo led to GC collapse, which indicated an essential role for c-Myc in GCs. Our results have implications for the mechanism of GC selection and the role of c-Myc in lymphomagenesis.
Germinal centers (GCs) are transient structures that form in secondary lymphoid organs. In these structures, B cells are selected on the basis of their ability to produce high-affinity antibodies [1] [2] [3] . The GC reaction is triggered by T cell-dependent antigens, in response to which B cells initiate vigorous proliferation coupled with somatic hypermutation of their immunoglobulin genes. These events take place in the dark zone (DZ) of GCs 4 and produce B cell populations that express B cell antigen receptors (BCRs) at the cell surface with a range of affinities for the initiating antigen. DZ B cells quickly transit to the light zone (LZ) 5, 6 , where they exit the cell cycle and are selected, on the basis of the affinity of their mutated BCRs, to differentiate into memory B cells or plasma cells [1] [2] [3] .
After selection, B cells can also reenter the DZ for additional cycles of somatic hypermutation and division, in an iterative process known as 'cyclic reentry' 6, 7 . Thus, GC development requires coordinated signals that dictate the induction of proliferation, exit from the cell cycle, cyclic reentry and differentiation, as well as the elimination of nonselected B cells by apoptosis. Those signals and their corresponding nuclear effectors are only partially understood, in part because the GC reaction cannot be reproduced in vitro. Nevertheless, their elucidation is important not only for the understanding of normal GC physiology but also for an explanation of the pathogenesis of B cell lymphomas, most of which are derived from and are thought to represent deregulated phenotypes of GC B cells.
Analysis of the gene-expression profiles of purified GC B cells (originally identified as centroblasts and centrocytes) has provided a descriptive and schematic picture of the phases of GC development by identifying genes specifically expressed in these populations 8, 9 . Some of these genes have been shown, through ablation in mice, to encode molecules with essential roles in GC formation [10] [11] [12] . In particular, analysis of the genes targeted by Bcl-6, a transcriptional repressor required for GC formation and involved in lymphomagenesis, has shed light on several unique features of GC B cells 13 . These include Bcl-6-mediated suppression of cell-cycle arrest and plasma cell differentiation, modulation of the DNA-damage response and silencing of genes encoding antiapoptotic molecules such as 14) . However, those studies used bulk purified GC B cells or CD77 + or CD77 − GC B cell subpopulations, all of which represent heterogeneous mixtures of GC cells. Subsequently, the identification of additional markers for the isolation of mouse and human DZ and LZ GC B cells has led to more precise definition of their phenotypes, which, notably, seem to differ more in terms of functional status than differentiation stage 6 .
One unexpected finding common to several of the studies noted above is that expression of the transcription factor c-Myc seems to be extremely low 8 or almost completely absent 9 in bulk GC B cells. It is thought that c-Myc is ubiquitously expressed in proliferating cells, where it controls cellular processes necessary for normal cell growth and proliferation via transcriptional and nontranscriptional mechanisms, including ribosome biogenesis, metabolism, the cell cycle, DNA replication and telomere maintenance [15] [16] [17] . Thus, c-Myc has a fundamental role in all tissues undergoing rapid cellular population 1 0 8 4 VOLUME 13 NUMBER 11 NOVEMBER 2012 nature immunology A r t i c l e s expansion and renewal [15] [16] [17] . Therefore, the apparent absence of c-Myc RNA and protein from most GC B cells, along with the observation that the promoter of the gene encoding c-Myc is bound by Bcl-6, a known transcriptional repressor 14, 18, 19 , seemed inconsistent with the rapidly cycling, proliferative phenotype of GC B cells. That paradox, together with the growing idea that GC B cell populations may be more complex and heterogeneous than previously envisioned, prompted us to examine c-Myc expression in detail during GC development and to determine its role in the formation and maintenance of GCs.
RESULTS

Expression of c-Myc is restricted to a subset of LZ B cells
The issue of c-Myc expression in GC B cells remains a matter of debate. Although published studies have reported an almost complete absence of c-Myc protein and/or mRNA in total populations of purified GC B cells 9 , subsequent work has provided molecular evidence suggestive of c-Myc activation in the LZ of mouse and human GCs 4,6 . We therefore investigated whether we could detect c-Myc expression in specific GC subpopulations or at specific times during GC formation. Immunofluorescence analysis of human reactive lymph nodes and tonsils showed the presence of a small number of GC B cells that expressed c-Myc, located mainly in the GC LZ ( Fig. 1a) . Consistent with that observation, we found c-Myc mRNA and protein in B cells purified from the LZ of human tonsillar GCs (CXCR4 lo CD83 hi ) but not in their DZ counterparts (CXCR4 hi CD83 lo ) 4,6 ( Fig. 1b-d and Supplementary  Fig. 1) . The amount of c-Myc protein in LZ B cells was several-fold higher than that in naive tonsillar B cells. Similarly, immunofluorescence analysis of mouse lymphoid tissues after immunization of mice with sheep red blood cells (SRBCs) identified small numbers c-Myc + B cells in the LZ of GCs (Fig. 1e) . We confirmed that topographical polarity by flow cytometry analysis of lymphoid tissues from a 'reporter' mouse strain in which one copy of the endogenous Myc allele was modified to express a fusion of green fluorescent protein (GFP) and c-Myc (GFP-c-Myc) 20 (Fig. 1f,g and Supplementary Fig. 1 ). By this approach, we estimated that c-Myc + GC B cells accounted for ~8% (range, 5-10%) of all GC B cells in a 'mature' mouse GC (a 10-to 12-day steady-state GC polarized into LZ and DZ 2,3,21 ; Fig. 1f ). Thus, we reproducibly detected c-Myc expression in a small subpopulation of B cells in the LZ of both human and mouse GCs.
Kinetics of c-Myc expression during GC formation
B cells commit to the GC fate in response to T cell-dependent antigens shortly after being primed by T cells in the interfollicular areas and at the B cell-T cell border of secondary lymphoid tissues 22, 23 . Division of the GC into the LZ and DZ takes place only later in the response [1] [2] [3] and thus the presence of c-Myc + GC B cells in the LZ suggested that their appearance could be a late event in the GC reaction. To address this issue, we analyzed the timing of the appearance of c-Myc + B cells during the course of GC maturation ( Fig. 2a) . We crossed GFP-c-Myc mice to B1-8 hi mice, which bear a gene-targeted BCR that binds with high affinity to the hapten NP when paired with an endogenous immunoglobulin-λ light chain (called 'Igλ' here) 24 . We then transferred naive B cells from the allotypically marked (CD45.1 + ) offspring of the GFP-c-Myc × B1-8 hi cross into wild-type hosts and monitored the activity of the cells by flow cytometry analysis of GFPc-Myc expression at various times after immunization of the mice with NP-conjugated ovalbumin (NP-OVA) 6 . This protocol ensured the specific recruitment of B1-8 hi B cells to GC at the expense of the host B cell pool 25 . To monitor the kinetics of GC development, we also monitored the transferred cells for Bcl-6 expression, which is induced relatively early after commitment to the GC (3-4 d after immunization) and is maintained throughout the GC reaction (>15 d) 11, 26 .
As reported before 22, 23, 26 , immunization with NP-OVA triggered a T cell-dependent antigen response that began at the B cell-T cell border and interfollicular areas and progressed to mature GCs by days 5-8 after immunization ( Supplementary Fig. 2) . Coincident with the initial expansion of the CD45.1 + donor cell population, an early peak of GFP-c-Myc expression occurred 1-2 d after immunization in small clusters of B cells located in the interfollicular areas and, less frequently, at the B cell-T cell border ( Fig. 2b and Supplementary  Fig. 2 ). By day 4, the frequency of c-Myc-expressing cells had rapidly decreased coincident with the progressive acquisition of Bcl-6 expression, a marker of commitment to the GC fate ( Fig. 2b and Supplementary Fig. 2 ). At this time (day 4), most c-Myc + cells were located mainly in small Bcl-6 + clusters in B cell follicles that corresponded to early GCs ( Supplementary Fig. 2c-e ). From day 4 to day 8, the number of cells in each developing GC increased exponentially (equivalent to ~10-12 population doublings that accounted for ~70% of the total CD45.1 + Igλ + B cell pool by day 8; Fig. 2c and Supplementary Fig. 2 ) as the total number of c-Myc + antigen-specific B cells in these GC clusters decreased progressively, before increasing again in mature GCs (day 8; Fig. 2c and Supplementary Fig. 2f ). The topographic distribution of c-Myc + cells in the GCs also changed, shifting from the sparse distribution in early GCs (days 4-5; Fig. 2d and Supplementary Fig. 2e ) to the 'preferential' location in the LZ of mature GCs (day 8; Fig. 2d ). These observations indicated that during T cell-dependent immune responses, c-Myc expression was induced early during B cell priming, was progressively suppressed during early GC expansion and DZ formation and was then reinduced in a subpopulation of LZ B cells at the time when the LZ and DZ segregate and GC selection begins.
Bcl-6 directly represses Myc transcription in DZ B cells
The progressive decrease in c-Myc + cells at the onset of the GC reaction suggested that c-Myc expression might be actively regulated in this compartment. Bcl-6 is a candidate c-Myc repressor in this setting because it binds to the promoter region of the gene encoding c-Myc in pre-B cells and transformed B cells 14, 18, 19 , and its expression seemed to coincided with a decrease in c-Myc expression during the early stages of GC formation ( Fig. 2 and Supplementary Fig. 2 ). Consistent with that hypothesis, and analogous to the pattern of c-Myc expression in mouse B cells, immunofluorescence analysis of human secondary lymphoid tissues confirmed that expression of c-Myc and Bcl-6 in mature GCs was inversely correlated in most GC B cells, with the majority of GC B cells expressing either c-Myc or Bcl-6 (~91% of all GC B cells; Fig. 3a and Supplementary Fig. 3 ) and only a small fraction (~8%) of GC B cells showing coexpression of both proteins ( Supplementary Fig. 3b,c) . Accordingly, the amount of Bcl-6 mRNA and protein (as measured by mean fluorescence intensity after specific immunostaining) was significantly lower in c-Myc + GC B cells than in c-Myc − GC B cells (P < 0.0001; Supplementary Fig. 3d ).
We isolated human GC B cells from reactive tonsils and analyzed them by chromatin immunoprecipitation (ChIP) and microarray. This confirmed the physical binding of Bcl-6 to the MYC promoter within a region of ~2 kilobases 5′ of the transcription start site ( Fig. 3b and Supplementary Table 1 ). ChIP followed by quantitative PCR analysis of DNA confirmed the existence of two adjacent Bcl-6-binding sites that, after sequence analysis, we found included two clusters of consensus Bcl-6-binding sites (the B6BS and M0 sites defined before 14 ; Fig. 3b,c) . Binding of Bcl-6 to the MYC promoter seemed to occur equally in LZ and DZ GC B cells ( Supplementary Fig. 3e,f) . To verify the regulatory role of these binding sites, we did transient transfection assays with a reporter construct in which the MYC promoter region identified above (Fig. 3b) drove the transcription of a luciferase reporter gene (Fig. 3d) . These assays showed dose-dependent repression of luciferase expression by Bcl-6 in human embryonic 
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A r t i c l e s kidney (HEK293T) cells ( Fig. 3d) and B cell lines ( Supplementary  Fig. 3g-j) , which was dependent on the DNA-binding and transrepressor domains of Bcl-6 ( Fig. 3d ) and required the presence of consensus Bcl-6-binding sites (Fig. 3e) . The residual repression activity (<20%) observed after mutation of those two main consensus binding sites ( Fig. 3e ) could have been explained by the presence of Bcl-6binding motifs with lower affinity, such as M0 sites (Fig. 3b ). Together these results indicated that Bcl-6 directly repressed MYC transcription Fig. 4 and Supplementary Table 2 ). LZ GC B cells showed considerable enrichment for this gene signature, as we predicted on the basis of the immunofluorescence and flow cytometry data ( Supplementary  Fig. 4c ). This gene signature included the following two features: the expected upregulation of c-Myc target genes, with substantial representation of genes encoding molecules involved in metabolism, a finding consistent with the significant enrichment for c-Myc target gene signatures detected in the GFP-c-Myc + population by gene-set enrichment analysis 27 ( Table 1, Supplementary Table 3 and Supplementary Fig. 4 ); and the upregulation of genes encoding cell-surface and adhesion molecules and cytokine receptors (such as Cd70, Cd59a, Cd47 and Vcam1). This analysis also showed the coordinated upregulation of early-response genes (Egr2, Socs3, Irf4, Nfkbi, Il10 and Batf) and genes encoding molecules involved in cell-cycle entry (Ccnd2, Cdk4 and Cdk6), which coincided with the enrichment for gene signatures related to activation of the immune response ('immune ativation'; that is, in response to BCR, CD40 and interleukin 2 signaling 8, 28, 29 ) and expression of the cytidine deaminase AID (encoded by Aicda) in a substantial fraction of GFP-c-Myc + cells ( Fig. 4a-e, Table 1 and Supplementary Tables 3  and 4 ). Consistent with the activated phenotype, the GFP-c-Myc + GC B cells were actively cycling (G0-G1 to S phase), in contrast to the quiescent nature of the remaining LZ GC B cells (Fig. 4f,g) .
As only positively selected GC B cells are expected to be activated and reenter the cell cycle in the LZ 6 , we hypothesized that c-Myc + cells in the LZ might bear BCRs of higher affinity, which would lead to their positive selection. To address this possibility, we analyzed the antibody repertoire of GFP-c-Myc + B cells sorted from GCs of GFP-c-Myc mice immunized with NP conjugated to keyhole limpet hemocyanin (NP-KLH). In C57BL/6 mice immunized with NP-KLH, substitution of leucine for the tryptophan at position 33 (W33L) in complementarity-determining region 1 of the variable heavy-chain region 186.2 is associated with high affinity for the NP hapten 21, 30, 31 . On day 9 after immunization, GFP + cells in the GC LZ (the CXCR4 lo CD83 hi population) showed more enrichment for W33L + sequences than did their GFP − LZ counterparts (~22% versus ~1%, respectively; Fig. 5 and Supplementary Table 5 ). GC cells sorted from the DZ (CXCR4 hi CD83 lo ) had an intermediate proportion of W33L + cells (~5%), which probably reflected the absence of selection in this compartment. Together these results suggested that the c-Myc + B cells in the GC LZ represented cells that were being actively selected for their high-affinity BCRs. 6, 22, 32 . GFP-c-Myc + B cells expressed Cd70 (Fig. 4b) , which encodes a surface protein of the tumor-necrosis factor family that is transiently induced in B cells by 33, 34 . The robust upregulation of CD70 mRNA in GFP-c-Myc + GC B cells correlated with its surface expression, which was restricted and specific to this GC population ( Supplementary Fig. 5 ). This finding suggested that c-Myc + GC B cells might be involved in productive interactions with T cells, an idea also supported by the observation that c-Myc + GC B cells were located mainly in the vicinity of LZ CD3 + T cells (as shown by immunofluorescence analysis; Supplementary Fig. 5c ).
Induction of c-Myc in LZ B cells by T cell selection LZ GC B cells with high-affinity receptors gain access to T helper cells, which leads to their positive selection
To test the hypothesis that access to T cell help and GC positive selection involve the induction of c-Myc expression, we mimicked the events that take place in the GC during affinity-based selection through the use of antigen delivery mediated by the surface lectin DEC-205 (CD205; Ly75). In this system, a T cell antigen (OVA) fused to a chimeric antibody specific to DEC-205 (OVA-anti-DEC-205) is used to deliver antigen to DEC-205-expressing, NP-specific B cells in an otherwise DEC-205-deficient GC 6 . Targeted antigen delivery induces an increase in the presentation of peptide by major histocompatibility complex on DEC-205 + B cells, which leads to their efficient interaction with GC T cells and subsequent selection for cyclic reentry or differentiation into plasma cells 6 (Fig. 6a) .
As reported before 6 , injection of OVA-anti-DEC-205 resulted in the retention of DEC-205 + GC B cells in the LZ at 12 h after treatment, followed by their accumulation and population expansion in the DZ at 40 h (Fig. 6b) . While in the LZ (12 h), these cells showed specific upregulation of Myc, Cd70 and Ccnd2 mRNA compared with their expression in DEC-205 − B cells in the same compartment (Fig. 6c,d) .
We thus concluded that access to T cell help triggered c-Myc expression in LZ GC B cells, which established c-Myc expression as a true marker of positive selection in the GC.
GC maintenance requires c-Myc
According to the cyclic reentry model, affinity-based selection of B cells in the LZ results in initiation of the cell cycle and return to the DZ. This selective flow of cells feeds the proliferating pool in the DZ and is required for maintenance of the GC 3, 6, 7, 35 . Having established a direct correlation among c-Myc expression, high BCR affinity and T cell-mediated selection (Figs. 4 and 5) , we investigated whether c-Myc was in fact required for maintenance of the GC through cyclic reentry. To block the biological activity of c-Myc, we took advantage of a published combined 'Tet-on' mouse model in which sequence encoding Omomyc, a selective c-Myc antagonist 36 , is placed under the control of a tetracycline-inducible element responsive to an rtTA transgene driven by a cytomegalovirus enhancer-Actb (encoding β-actin) promoter 37, 38 . Omomyc causes considerable perturbation of the c-Myc transcriptional programs by abrogating the ability of c-Myc to bind canonical target genes, which leads to cell-cycle arrest and apoptosis in a c-Myc-dependent manner 37, 39 . As c-Myc expression in Supplementary Fig. 1 ). (c) Fraction of variable heavy-chain region 186.2 segments (complementarity-determining region 1) with the W33L substitution (W33L + ), among all sequenced segments (W33L mutants/ total segments; additional details, Supplementary Table 5 ) in populations 1-3 identified in a; W33L − , segments without the W33L substitution. *P = 0.211, **P = 0.001 and ***P < 0.0001 (Fisher's exact test). Data are representative of two experiments (b) or are pooled from two independent experiments with two to three mice each (with ~45-50 clones per sample in each; c). the GC was restricted to B cells (B220 + ) and was specifically absent in follicular helper T cells (CD4 + CXCR5 + PD1 + ) or non-lymphoid GC cell types (B220 − CD4 − ) ( Supplementary Fig. 6 ), we reasoned that the induction of Omomyc expression by treatment with doxycycline would have cell-autonomous effects only in B cells. We allowed GCs to develop for 10 d after immunization of mice with SRBCs, then induced Omomyc expression for an additional 5 d (Fig. 7a) . This treatment led to a ~50% lower frequency of GC B cells (B220 + PNA hi CD95 hi cells) than in mice in which Omomyc expression was not induced (Fig. 7b,c) , and a much lower average size of GCs, with a considerable fraction of the remaining GCs being composed of clusters of no more than five to ten Bcl-6 + B cells (Fig. 7d,e ). We observed no substantial effect on the number of GCs in wild-type mice exposed to doxycycline (Fig. 7c) . Omomyc expression was much lower in the few GCs of normal size than in the non-GC B cell population ( Fig. 7f) , which suggested suboptimal induction of Omomyc through either limited delivery of doxycycline or variability in the induction of or response to the rtTA transgene 40 . Together these data indicated that c-Myc was required for GC maintenance.
DISCUSSION
Our results have shown that c-Myc expression was restricted to the following specific phases of GC development: during the initial population expansion of naive B cells after antigenic priming, and in stages immediately preceding the LZ-to-DZ transition in mature GCs. The expression of c-Myc was repressed in the GC DZ. This specific pattern of expression clarifies and corrects published observations about the absence of c-Myc expression in GC B cells 8, 9, 41, 42 . Notably, c-Myc expression was concurrent with important positive selection checkpoints that promote the survival and proliferative expansion of affinity-selected B cells during the GC reaction. Our findings have direct implications for the understanding of GC physiology, GC and pre-GC selection and the role of chromosomal translocations that deregulate c-Myc expression in B cell lymphomas.
We observed transient expression of c-Myc in the few B cells interacting with the antigen and accessing T cell help during the early steps of GC commitment, before the induction of Bcl-6 expression. Subsequent suppression of c-Myc expression was caused at least in part by active transcriptional repression by Bcl-6. That conclusion was based on kinetic data showing the disappearance of c-Myc expression at the time of Bcl-6 induction; on the binding of Bcl-6 to the promoter of the gene encoding c- Myc 14, 18, 19 ; and on our evidence that Bcl-6 directly repressed transcription of MYC. The signals thought to initiate the GC reaction-engagement of the BCR, CD40 and cytokine receptors (such as the receptor for the T cell-derived cytokine interleukin 2)-are known to negatively regulate Bcl-6 activity 13, 43 . Such signals would allow c-Myc to escape repression by Bcl-6 during the first rounds of cell division that give rise to the bulk of GC B cells. The transient nature of these signals, and the decreasing number of positive selection events found in GCs as they mature 21 , would explain why c-Myc is not detectable in most 'mature' GC B cells 8, 9 . Although this issue was not directly addressed by our studies, c-Myc is required for initiation of the GC reaction, as demonstrated by the lack of GCs in mice in which Myc is ablated early during GC induction 44 .
The finding that Myc transcription was suppressed by Bcl-6 in DZ B cells explains published studies reporting a low abundance or absence of c-Myc in GC B cells and, more specifically, in DZ cells 6, 8, 9 . In fact, the nearly complete absence of c-Myc expression in DZ cells (which represent over two thirds of all GC cells in mice and humans 4, 6 ) and in the majority (>90%) of LZ cells interferes with its detection in the small c-Myc + subset of LZ cells during analysis of bulk GC populations. We have shown that this obstacle can be overcome by use of assays with single-cell sensitivity (such as histology and flow cytometry) or by the separate analysis of fractionated LZ and DZ populations 4, 6 .
One question that remains unanswered is why c-Myc expression must be actively repressed in dividing DZ B cells, an observation at odds with the widely accepted idea of c-Myc as a proliferation marker in most tissues [15] [16] [17] . One possibility is that repression of c-Myc is needed to limit the rounds of cell division in the DZ, which is consistent with the idea that only a single round of cell division may be required before each round of affinity-based selection 3, 7 . In addition, Figure 7 The biological activity of c-Myc is required for normal GC maintenance. T cell-mediated selection induces the reentry of selected LZ cells into the DZ for further rounds of proliferation and hypermutation but also triggers their differentiation into plasmablasts 6, 48 . This raises the question of whether c-Myc expression is required for cyclic reentry (and therefore for GC maintenance) or is instead upregulated only in cells leaving the GC as plasmablasts, which express the plasma cell marker and transcriptional repressor Blimp-1 (encoded by Prdm1) and are therefore in the process of downregulating Bcl-6 (ref. 13) . Our data are consistent with the first possibility, given that blockade of c-Myc activity in mature GC B cells led to the collapse of the GC, which would not occur if c-Myc + cells were simply destined to exit the GC. Except for the transcription factor IRF4, which can also be induced early in response to 'immune activation' signals 8, 28 , the gene-expression profile of isolated c-Myc-expressing LZ GC B cells did not show signatures of commitment to differentiation into plasma cells (such as Blimp-1 expression 8, 48 ). Thus, we speculate that c-Myc induction may specify reentry into the DZ rather than differentiation into plasma cells.
The specific pattern of c-Myc expression during GC development has implications for the understanding of c-Myc-driven lymphomagenesis. Chromosomal translocations involving immunoglobulin loci and MYC occur in all Burkitt lymphomas and a fraction (~20%) of diffuse large B cell lymphomas 49, 50 , probably as a result of abnormal AID activity on an actively transcribed MYC locus 50 . The coexpression of c-Myc and AID proteins in a fraction of c-Myc + GC B cells suggests that these events occur in this specific GC B cell subpopulation. Lymphoma-associated translocations, which juxtapose transcriptional control elements in the immunoglobulin locus to the MYC promoter and in some cases remove the Bcl-6-binding sites in the MYC 5′ region, may override Bcl-6-mediated repression because of strong enhancer activity of immunoglobulin genes. These mechanisms can thus prevent the suppression of MYC transcription by Bcl-6 in the DZ and, notably, uncouple c-Myc expression from positive selection. Consistent with that idea, Burkitt lymphomas have geneexpression signatures that represent an admixture of those of DZ B cells and c-Myc-dependent signatures that are otherwise confined to the LZ 4 . Therefore, by overriding the physiological control of c-Myc expression at critical checkpoints in the GC reaction (entry into the GC and reentry into the DZ), translocations involving immunoglobulin loci and MYC may allow B cells to bypass affinity-based selection signals and impose a continuous reentry phenotype that, by perturbing normal GC dynamics, may contribute to lymphomagenesis.
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